Find uplifting stories about heroes, innovations, and solutions
15 results for "multiple myeloma"
A breakthrough oral medication helped multiple myeloma patients live 18 months without their cancer worsening, more than double the time compared to standard treatment. The results offer fresh hope for thousands of people whose cancer has stopped responding to other therapies.
Scientists have developed an AI system that reads bone marrow slides to match multiple myeloma patients with the treatments most likely to work for them. The breakthrough could help doctors personalize cancer care and spare patients from harsh therapies they don't need.
Artificial intelligence can now analyze routine bone marrow slides to predict which multiple myeloma patients need aggressive treatment and which can safely choose gentler options. The breakthrough could transform how doctors personalize cancer care.
A groundbreaking cancer therapy that costs over $200,000 per patient is now free for eligible Australians thanks to a landmark government funding deal. The treatment has already given patients like Phil Citera a second chance at life.
Cancer researchers are celebrating a major win in the fight against multiple myeloma as death rates decline thanks to breakthrough targeted therapies. Patients diagnosed with this once-deadly blood cancer now have more reasons for hope than ever before.
Twenty people with smoldering multiple myeloma have zero detectable cancer cells after receiving an aggressive immunotherapy treatment. The results are so complete that researchers are cautiously using a word they usually avoid: cure.
A blood cancer treatment that works like a "Trojan horse" to destroy cells from within just received approval in New Zealand, offering hope to 2,500 patients with multiple myeloma. One patient who joined the trial says the drug gave her confidence to believe in her future again.
A breakthrough immune therapy is transforming multiple myeloma from a disease that always returned into one where patients can reach long-term remission. More than 36,000 Americans diagnosed this year now have access to treatments once considered impossible.
After beating multiple myeloma twice through clinical trials, Julie Cohen turned her battle into a mission. She now dedicates her life to coaching other cancer patients through their darkest moments.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
A groundbreaking combination therapy for multiple myeloma just won FDA approval, nearly tripling survival rates compared to standard treatment. This could become the new standard of care for thousands of cancer patients facing relapse.
A groundbreaking clinical trial shows 83% of multiple myeloma patients remained cancer-free for three years using a two-drug immunotherapy combination. The FDA fast-tracked approval in just four months, offering real hope that this once-incurable cancer may now be curable for most patients.
Scientists discovered how cancer cells hide from cutting-edge immunotherapy and used an existing drug to make the treatment work again. Six patients whose immune cell therapy had stopped working saw their cancer respond once more.
Cancer patients fighting multiple myeloma can now skip painful bone marrow tests thanks to a breakthrough blood test available at 7,000 locations nationwide. The affordable new test detects lingering cancer cells just as accurately while costing far less than existing options.
Cancer patients with multiple myeloma can now track their treatment progress with a simple blood draw instead of painful bone marrow biopsies. This breakthrough makes monitoring minimal residual disease faster, easier, and less painful for thousands of patients.